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ives. We sought to investigate whether reduced respira- 
scle endurance contributes to incmased dyspnea and 
&reascd enercise capacity in tients with chronic heart failure. 
n patients with heart lake, the sensation of 
dy related to abnormalities of respiratory muscle 
knction, such as dlminirhed strength or endurance, or both. 
M&t&, Respiratory muscle endurance was assessed by mea- 
suring mal sustainable ventilatory capacity in IS patients 
with co ive heart failure and 8 normal subjects using progres- 
sive isocapnk hyperpnea. Near-inked spectroscopy of an acces- 
soq resphutory muscle, Borg scale recordings of perceived dys- 
pnea, time in inspiration, time per breath and minute ventilation 
were measured. Exercise testing with measurement of oxygen 
consumption was also performed. 
le d~xy~e~latio~ was in either grow 
ings at maximal susta tilatory crpaci 
in both groups. At rest, the i~spi~to~ duty cycle 
(Le., time in inspiration divided by tbc time per breath) was 
comparable in the two groups (normal subjects 0.34 f 0.09, heart 
failure group 0.37 + 0.12, p = NS). However at maximal sustoin- 
able ventilatory capacity, only uornlal subjects bad a signiticunt 
increase in the inspiratory duty cycle (normal subjects 0.49 2 
0.04, heart failure group 02% f 0.10, p -C 0.05). This finding 
suggests obstruction to airtlow in patients with congestive heart 
failure. Values for peak exercise minute ventilation did not differ 
significantly from values in maximal sustainable ventilatory ca- 
‘ther group and were significantly cor~lat~~ (r = O.Sd, 
&sufis, Maximal voluntary ventilation (normal subjects 167 f 
40, heart failure group 89 A 31 literslmin) and maximal sustain- 
able ventilatory capacity (normal subjects 90 * 23, heart failure 
group 53 * 22 literslmin) were significantly reduced in patients 
with heart Catlure (both p -=z 0.05). No signifimt accessory 
Conclusion. Respiratory muscle endurance as assessed by 
maximal sustainable ventilatory capacity is reduced in patients 
with heart failure. 
(1 Am Co11 Cardiol1994:24:972-81) 
Skeletal muscle histochomical and mctaholic abnotmaiitics 
have been described in patients with heart failure, including 
generalized muscle atrophy and a shift from oxidative to 
glyeolytic metah>lism (l-7). A aduction in the endurance of 
limb skeletal muscle has also been described (8). These 
intrinsic skeletal muscle ahnormalities may exacerbate the 
exertional fatigue experienced by patients. Analogously, dys- 
pneo may be exacerbated by abnormalities in the respiratory 
muscles. The work of breathing is greatly increased in patients 
with heart failure (9,lO). Respiratory muscle strength tends to 
be reduced (1 I). Accessory respiratory muscle deoxygenation 
occurs during exercise in patients with heart failure but not 
normal suhjccts (12). Perceived dyspnea during submaximal 
exercise is significantly correlated with variables of rcFpiratory 
anuscle function (12-14). No previous studies have measured 
the endurance of the respiratory muscles in patients with 
congestive heart failure. 
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The purpose of the present study was to determine whether 
respiratory muscle endurance is reduced in patients with 
chronic heart failure. Progressive isocapnic hyperpnea was 
used to measure maximal sustainable ventilatory capacity and 
thus assess respiratory muscle endurance. We also sought to 
investigate whether diminished respiratory muscle endurance 
contributes to the exercise limitation of patients with heart 
failure. WC hypothesized that if maximal sustainable ventila- 
tory capacity greatly exceeded peak exercise minute ventila- 
tion, sufficient pulmonary reserve would exist to preclude 
respiratory muscle dysfunction as a potential limiting factor to 
peak exercise performance. However, close matching between 
maximal sustainable vcntilatory capacity and peak exercise 
minute ventilation would suggest a previously unrecognized 
potential limitation to maximal exercise capacity. 
and addms for corrcswndencts Dr. Donna M. Mancini, 
Cohnuhia-Pre$yterian Hospital, 622 West 168 Street, New York, New Yark 
10032. 
Study patients. The study group consisted of 15 patients 
(12 men, 3 women) with congestive heart failure due to 
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iscase (n = 8) or 
(n = 7). The mean age 2 S was 58 t I2 years, Ejection 
fraction averaged 19 + 7%. Peak o ConSumQtiOn WXi 
11.4 + 3.4 ml/kg body weight patient was in New 
sociation f~~cti~)n~~ class 1, three patients were 
I in class 111 and three in class IV. Fourteen of 
bad previously undergone right heart catheter- 
ization. Right atrial pressure average 12 f 5, mean pulmo- 
nary artety pressure 3 + 8 and pulmonary capillary wedge 
pressure 20 2 X mm g. Cardiac index averaged 1.8 ? 0.4 
liters/min per in’. All patients were receiving digoxin, diuretic 
agents and angiotensin-converting enzyme inhibitors. Average 
height was 68 2 4 in. (173 t IO cm); average weight was 172 
+ 4X lb (77 I? 22 kg). Eight normal subjects (7 men, I wotn~m) 
with an average age of 50 I- IO years ah Qarticipatcd in the 
study. Avcragc hcigbt W;LS 6 ‘! k 5 in. (175 2 13 cm); average 
wcigbt was Its0 -C 45 Ib (82 t 20 kg) (all p 2 0. I VC~S~K heart 
failure). All tight normal suhjccts wcrc currently nonsmokers 
without iL prior history of pulnronaty discasc. Scvcn of the IS 
patients had a past history of smoking (32 ? 27 pack-years) but 
had discontinued smoking 8 ri- 7 years ago. Pulmonary function 
tests were performed to exclude significant lung disease in all 
but two patients with hcnrt failure an average of I3 ? 8 months 
before enrollment in the study. 
The protocol was approved by the Human Studies Subcom- 
mittee at the Philadelphia Veterans Administration Medical 
Center and the Committee on Studies Involving Human 
Beings at tbc Hospital of the University of Pennsylvania. 
Written informed consent was obtained from all subjects. 
Exercise tesiimg. Maximal treadmill exercise testing with 
respiratory gases was performed using the 3-min moditied 
Naughton protocol in patients with heart failure and the Bruce 
protocol in normal subjects. Measurements of expired volume, 
mixed cxpircd oxygen and mixed cxpircd carbon dioxide were 
determined at rest and every 30 s throughout exercise with the 
use of a metabolic cart (SensorMedics). One patient with heart 
failure was unable to perform treadmill exercise because of a 
prior cerebrovascular accident. 
Maximal sustainable ventilatory capacity. Maximal sus- 
tainable ventitatory capacity was measured on a separate 
day from maximal exercise testing. On the subject’s arrival 
in the exercise laboratory, maximal inspiratory and cxpira- 
tory mouth pressures were measured in triplicate at residual 
volume and total lung capacity, respectively. Maximal vol- 
untary ventilation was then measured in duplicate. Forced 
expiratory volume in I s (FEV,) was derived by dividing 
maximal voluntary ventilation by 35 (15). Near-infrared 
fiberoptic light guides were placed on the sixth intercostal 
space at the anterior axillary line over the serratus anterior 
muscle, an accessory inspiratory muscle. The seated subject 
then breathed into a maximal sustainable ventilatory capac- 
ity apparatus with monitoring of end-tidal carbon dioxide 
(CO,). Inspiratory and expiratory ventilation was monitored 
by pneumotachograph. Pulse oximetry, heart rate, blood 
pressure and Borg scale ratings of dyspnea (16) were 
monitored throughout the test. 
ur application of near-infrared spectrosc ‘to monitor 
accessory i-C’SQil-&JIy de o~~gena~joi~ has 
described (12.17). 
n previously 
Bri near-infrared spectroscopy noninva- 
sively assesses skeletal scle oxygenation. Both oxygenated and 
dcoxygenated hemoglobin absorb light at 8uO nm, whereas pri- 
marily deoxygenated hemoglobin absorbs light at 760 nm. There- 
fore, by monitoring the difference in absorption noted at these 
two wavelengths, it is possible to assess changes in hemoglobin 
oxygenation (18). The difference in absorption at 760 nm versus 
that at 800 nm was used to assess serratus anterior muscle 
oxygenation. All studies wete performed at the Same gain settings 
on the spectrometer. Absorption changes were then expressed as 
arbitrary units of deviation from a stable baseline. The higher the 
arbitrary unit, the greater was tbe rnusclc deoxygenation. A 
negative vahtc represents hyperoxygenation. The XOO-nm absorp- 
tion cww was used to assess total hemoglobin concentration and, 
thus, changes in blood volunic. 
Wc (Is)) have previously used the maximal sustainable 
vcntilatoly GlQilCity rcbrezithing circuit. A graduated flow 
meter (Fisbcr and Porter Corporation) was adjusted to a set 
ntercd a S-liter anesthesia bag (model 5-035- 
ennett Corporation) that then passed into a 
(,-liter mixing chamber that then went to the patient who 
inspired this air through a two-way nonrehreatbing llllS 
Rudolph valve. The subject was instructed to regulate his 
breathing so that the folds in the 5-liter target bag were always 
prominently displayed. No further instructions were provided. 
Exhaled air was then recirculated through a variable flow CO, 
scrubber circuil. The (j-liter dead space mixing chamber served 
to humidify the inspired air. Inspiratory and cxnpiraiory fro-W 
rates were monitored with pncumotachographs interfaced in 
the airhow circuit (model 38W, Hans Rudolph). The pneumo- 
tachogrdphs were connected to a variable reluctance pressure 
transducer (model MP 45-871, Validyne Engineering). Vcnti- 
latory frequency, minute ventilation, inspiratory time per 
breath and the inspiratory duty cycle (i.e., fraction of breathing 
cycle spent in inspiration) were derived from these signals. 
lsocapnia was maintained throughout the test. End-tidal 
CO, was monitored with a mass spectrometer (Pcrkin-Elmer) 
by continuous satnpling of air from a mouth port. Carbon 
dioxide levels were displayed on an oscilloscope with CO, 
concentration controlled by varying flow through the CO2 
scrubber circuit. This circun consisted of a canister containing 
COz absorbent granules (Barium Hydroxide Lime, Warren E. 
Collins) and a variable speed blower (model 20I 17, Warren E. 
Collins) which were connected to both ends of the dead space 
portion of the apparatus. Excess CO, was removed and 
supplemental CO2 added as determined from end-tidal CO, 
readings. Carbon dioxide concentration was maintained at 3% 
to 5%, which corresponded to end-tidal CO2 of the patients at 
rest (i.e., 35 to 40 mm Hg). Oxygen concentration was also 
adjusted according to pulse oximelry readings. SupQlCmental 
oxygen was added if the oxygen saturation decreased to <o(Y%. 
Each subject began isolated respiratory muscle exercise at a 
work load of 200/u of his or her maximal voluntary ventilation. 
Work loads were of 3-min duration and increased by 10%~ 
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T&k 1. fitmonaq Function Tests in Normal Subjects and Patients 
With Heart Failure 
Normal CHF 
(n = 8) (n = IS) 
Maximal inspimtory ~KSSU~C (kPa) 35 f 3 299-t 14 
Maximal expiratory pressure (kPa) b22t 13 50 2 23 
M&mat vohmfary venlilation 
In liters 167 + 40 89 + 31” 
% predislud 116 + 28 73 2 22’ 
FEV, (liters) 4.8 t I.1 2.5 _+ U.9* 
*p r; 0.05, normal subjt~& versus palien6 with heart failure (CHF). Dat;l 
prmnled arc mean value ?t SD. FEV, = forced uxpiratory volume in I s; kPa = 
tilopascrrls. 
increments to a maxima! tolerated Ievc!. Maxima! sustainable 
vcntilatory capacity was detined as the highest work !oad 
comptctcd, Minute ventilation, time in inspiration, breathing 
frequency and time pr hrcath were derived from an average of 
breaths during the last minute of each work load. 
This method of dctcrmining maxima! sustainable vcntila- 
tory capacity varied from traditional approaches, which use 
!S.min work loads !@nning at 70% of maxima! voluntary 
ventilation (19). In six normal subjects, maxima! sustainable 
ventilatory capacity was randomly measured by both ap 
proachcs. The results of measurement of maxima! sustainable 
ventilatoty capacity by the incremcnta! test and the traditional 
approach were comparable (incremental maxima! sustainable 
ventilatory capacity 80 + 14, traditiana! maxima! sustainable 
vcntilatory capacity ?XI St 12 litcrs/min, p = NS). 
Statistical analysis. Ihtit from patients with hoart failure 
and normal subjects at rest and during maxima! sustainable 
ventilatory capa;ity were compared with Student’s paired or 
nonpaired I tc!ds or two-way rcpeatcd analysis of variance as 
appropriate. The relations bctwccn variables were examined 
by linear regression analysis. A value of p < 0.05 was consid- 
ered signiticant. Data arc expressed as mean value ?I SD. 
Results 
Pulmonary Sanction tests. Table I contains the results of 
measurement of respiratory muscle strength and maxima! 
voluntary ventilation measured at t!le time of the determina- 
tion of maxima! sustainable ventilatory capacity. Maxima! 
inspiratory and expiratory pressures tended to be lower in 
patients with heart failure than in normal subjects but the 
difference did not reach statistical significance. In the heart 
failure group, maxima! voluntary ventilation was significantly 
reduced as were percent of predicted maxima! voluntary 
ventilation and FEV, estimated from maxima! voluntary ven- 
tilation. 
Maximal exercise measurements. At rest, patients with 
heart failure and normal subjects had comparable values for 
subjects 81 c 12, heart failure group 87 t 
14 beats/min); oxygen consumption (normal subjects 4.2 + 0.0, 
heart failure group 4. I -t 0.6 ml/kg per min); minute vcntila- 
tion (normal subjects 12.6 9 2.4, heart failure group 13.7 ?I 2.7 
!itcrs/min); respiratory yuoticnt (normal subjects U.79 L 0.05, 
heart failure group 0.82 2 0.09) and arterial oxygen saturation 
(normal sulljccts 9X L I%, heart failure group 96 z!z 2%:) (a!! 
p 2 0.4). Qnly mean arterial blood prcssurc at rest was 
signifcantly rcduccd in the patients with heart failure (normal 
subjects % Z!C 10, heart failure group 84 + 9 mm Hg, p < 0.05). 
At peak exercise, heart rate (normal subjects 172 rt 14. 
heart failure group 119 t 20 beatslmin), mean arterial blood 
pressure (normal subjects 128 -C IS, heart failure group 95 + 
15 mm Hg), oxygen consumption (llOrllKi! su!)jccts 35.X 1‘ 13.5, 
heart failure group II.4 +- 3.4 ml/kg pr min) and mimrte 
ventilation (normal subjects 97 Z?I 25, heart failure group 48 2 
16 litctslmin) were signiticantly rcduccd in patients with heart 
failure (a!! p < 0.05). Arterial oxygen saturation (normal 
subjects 9S L YX, heart faiiurc group 93 2 YX), respiratory 
quotient (normal subjects 1.1 I 9 0.12, heart failure group 
I.05 -C 0.20) and level of perceived dyspnea yuantitated by the 
Borg scale (normal subjects 17 t- 2, heart failure group 16 2 2) 
comparable (al! p e 0.5). 
aximal sustainable ventiletory capacity. The heart rate, 
blood pressure response, arterial oxygen saturation and Borg 
scale recordings of dyspnea at rest and maximal sustainable 
ventilatory capacity are summarized in Table 2. A small but 
significant increase in heart rate occurred in both groups. 
Mean arterial blood pressure increased slightly in normal 
subjects. No significant arterial oxygen desaturation occurred. 
Tabk 2. Humodynumic and Pulmonary Variables at Rest and at Maximal Susttiinable Vcntilatoly 
Capacity in Normal Subjects and P;lticntS With Huart Failure 
RCSI MSVC 
Normal CHF Normal CHF 
tlcart rate (beal$min) 1s + I3 XS‘ I5 94 + 9” 97 + Id’ 
Mean blood pressu~ (mm Hg) 9b5 IO 85 c xt IUJ z II* 91 2 12t 
Arlcrial oxygen saturation (56) 98 ? I 97% I 97 r I 97 JI I 
Borg aele - - lb c 2 17-1-4 
TK” 0.34 f 0.09 0.37 2 0.12 0.49 * 0.04; U.36 -t U.lU* 
Respiratory rate (breathslmin) I4 t5 1827 74 ?I 2Yt 19 2 15*i 
Tidal volume (liters) I.1 ? 0.3 I.0 2 0.2 1.4 % 0.6 I.1 * 0.5 
*p < 0.05, rest versus maximal sustainable ventilatory capacity (MSVC). tp < 0.05, normal subjects versus patients with 
heart failure: (CHF). Data pmnted are mean value 2 SD. To,,,, = time in inspiration divided by total time per breath. 
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Figure 1. Near-infrilred absorption changes of 
the scrmtus anterior muscle at rest and during 
maximal sustainable ventilatory capacity (MVSC) 
in a normal subject snd a patient with congestive 
CWVC, SumulCd Sigllill Of 
ling tOtill blOOd VdUmlL 
dt~m curve, Dilfcrcnce in 7010- and NWnm 
;hwrptioa monitoring muscle OXy~LJlli~til~~l. 
Cnl = c;dihr;Nil\n; MVV z mi&lid VOIUU~~~~ 
vcnlilirliun. 
” & 1 I I 
0 3 6 9 I2 
Tams (min) 
Borg scale recordings at maximal sustainable ventilatory ca- 
pacity were comparable. Arterial oxygenation and end-tidal 
CO, remained constant throughout the studies. 
No significant accessory respiraiory muscle deoxygcnarion 
as assessed by near-infrared spectroscopy was obscrvcd in any 
of the normal subjects. Similarlv, minimal accessory respiratory 
muscle deoxygenation was observed in patients with heart 
failure (normal subjects -2.1 + 8.2, heart failure group 
-0.8 + 6.1 near infrared arbitrary units [AU!, p = 0.6). 
Representative near-infrared tracings from a normal subject 
and a patient with heart failure are illustrated in Figure I. The 
upper curve represents the summed signal and, thus, total 
blood volume. The lower curve reprcscnts the difference in 
absorption between 760 and 800 nm and, thus, skclctal muscle 
oxygenation. No significant deoxygenation is observed in either 
the normal subject or the patient with heart failure. This 
finding suggests that adequate perfusion of accessory respira- 
tory muscle occurs in both groups with isolated respiratory 
muscle exercise. In a prior study (13) we demonstrated signif- 
icant accessory respiratory muscle deoxygenation during max- 
imal bicycle exercise (normal subjects --3 _+ 6, patients with 
heart failure 28 + 5 AU, p < 0.001). 
Maximal sustainable ventilatory capacity was significantly 
lower in patients with heart failure than in normal subjects 
(normal subjects 90 f 23, heart failure group 53 t 22 
literslmin, p < 0.01). Figure 2 illustrates maximal sustainable 
ventilatory capacity measured in all 23 subjects. The ratio of 
maximal sustainable ventilatory capacity to measured maximal 
voluntary ventilation expressed as a percent was not signif- 
cantly diffcrcnt between the two groups (normal subjects 55 2 
9% heart failure group 05 2 25% p = 0.4), although the ratio 
of maximal sustainable vcnlilatory capacity to predicted max- 
imal voluntary vcntilalion was significantly less in the patients 
with heart failure (normal subjects 64 2 13% heart failure 
group 45 ? 15% p < 0.05). These findings arc consistent with 
Figure 2. Scattcrgram illustrating maximal susknahlc vcntilatory 
capkty in all sight normal subjects (NL) and all 15 subjects with 
congestive heart failure (CHF). Horizontal bars and symbols within 
them indicate SEM and mean values, rcspcctivcly. 
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Rest 
MSVC 
diminished respiratory muscle endurance in patients with h!ilt? 
hilutt. 
An cxnruplc of inspirutory and cxpiratory 9low rates in a 
normal subject and a patient with heart failure at rest and 
maximal sustainable vcntilatory cap&y is illustrated in Figure 
3. At rest the duty cycle-thilt is, the time in inspiration divided 
by the time per breath (Ti/T,,,)-was comparahlc in the two 
groups (normal subjects 0.34 2 O.OY, heart failure group 0.312 
0.12, p = 0.6). Power calculation showed that there was an 
8% power to detect that a differcncr: of 0.03 with a variance 
of 0.004 would have a type 1 error of p < 0.05. The duty tyclc 
gradually increased in normal subjects but not in p&Gents with 
heart failure. A signiticant linear correlation was observed 
between the duty cycle and minute ventilation in normal 
subjects (r = 0.66, p < 0.0001) but not in patients with heart 
failure (r = 0.04, p = 0.4). 
At maximal sustainable vcntilatory capacity, the duty cycle 
increased significantly in normal subjects to 0.49 z? 0.04 (p < 
Ml5 vs. rest), whereas it remained unckangcd at 0.36 -1- 0.10 in 
the patien!s with heart failure (p < 0.01 heart failure group vs. 
normal subjects). Tfiis increase in the duty cycle in normal 
subjects but not in the heart failure group suggests that 
patients with congestive heart failure may have obstruction to 
airflow, probably from bronchial edema, The reduction of 
inspiratory and expiratory flow rates as illustrated in Figure 3 
in the patient with heart failure at maximal sustaiddC venti- 
tiIt(JF Ci~pdty further supports airlilow obstructinn. 
At maximd sustainahlc VLWtililto~ Capacity, rtzspiratq 
rate was significantly less in patients with heart failure (normal 
subjects 74 % 28, heart failure group 49 + 25 breathslmin. p < 
0.05), whereas tidal votume was similar in the two groups 
(TaYc 2). 
Correlation of maximal sustainable ventilatory capacity 
with exercise and pulmonary funcHw testing. Maximal sus- 
tainable ventilatory capacity and ventilation at peak exercise 
were significantly lower in patients with heart failure than in 
normal subjects. However, within each group the two variables 
did not differ significantly (Fig. 4, top). Indeed, a tine of 
identity with a slope of 0.96, y intercept of 0.4 and r value of 
0.x4 was observed when ventilation at peak exercise was 
correlated with maximal sustainable ventilatory capacity (Fig. 
4. bottom). Analysis of each group individually also demon- 
strated modest significant correlations between maxima9 sus- 
tainable vcntiiatory capacity and peak minute ventilation (nor- 
mal subjects y = 0.81x + 11.0, r = 0.86, p < 0.01, heart failure 
group y = 0.93x + 12.0, r = 0.65, p < 0.02). Comparison of 
regression lines yielded no statistical difference (p = NS, F = 
1.1, degrees of freedom 1,97). 
Maximal sustainable ventilatory capacity and peak oxygen 
consumption were significantly correlated in all subjects (r = 
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Figure 4. Top, Histographs showing mean maximal sustainable vcnti- 
latory capachv (MSVC) and peak wxisc ventilation (VE) 2 SEM 
(w&al line j in normal subjects (NE) and patients with hurt failure 
(Cl-IF). Bottom, Linear correlation of maximal sustainahlc ventilatory 
capacity and peal\ cxcrcisc ventilation in all suhjucts. 
0.66, p < 0.01). However, individual group analysis did not 
demonstrate significant correlations (normal subjects r = 0.54, 
heart failure group r = 0.47, both p 2 0.5). 
To determine whether the maximal sustainable ventilatory 
capacity or the ratio of peak exercise ventilation to the 
maximal sustainable ventilatory capacity could predict the 
symptom that limited exercise, these values were compared in 
the nine subjects limited by dyspnca and the nine subjects 
limited by fatigue. Five subjects could not differentiate dyspnea 
or fatigue as the symptom that limited exercise performance. 
No significant differences were observed with either maximal 
sustainable ventilatory capacity (dyspnea-limited group 67 + 8, 
fatigue-limited group 67 2 11 liters/min, p = 0.6) or the 
derived ratio expressed as a percent (dyspnea-limited group 
94 + 7%, fatigue-limited group 105 I! 9%, p = 0.5). However. 
when the degree of perceived dyspnea noted at a submaximal 
work load (i.e., oxygen consumption -10 ml/kg per min) was 
correlated with maximal sustainable ventilatory capacity, a 
significant linear correlation was observed for all subjects (r = 
-0.77, p < 0.0001) and for patients with heart failure (r = 
-0.62, p < 0.05). 
Significant linear correlations were observed betweerl max- 
imal sustainable ventilatory capacity and indexes of respiratory 
Maximal inspiratory prc~rc 
Maximal expirakq pr~wr~ 
Forced expiratory volume in I s 
Maximal voluntay ventilation 
muscle strength such as maximal inspiratory and expiratolry 
pressures (r > 0.6, p < 0.01 for both). Significant correlations 
WCrC alsO ohSC!Ved between maximal sustainable velltilatq 
capacity aad FEV, derived from maximal voluntary ventila- 
thl, suggesting that airflow is also a significant factor deter- 
mining respiratoiy muscle endurance (r > 0.79, p < 0.(1001 for 
both) (Table 3). 
When maximal sustainable Vcntilatory capacity was normal- 
ized by FEV, and thus obstruction to airflow, no significant 
differences were observed between nolmal subjects and pa- 
tients with heart failure (normal subjects 18.8 r 2.9, heart 
failure group 22.1 2 8.7 min-‘, p = 0.3). However, similar 
normalization of maximal sustainable ventilatory capacity for 
muscle strength by maximal inspiratory or expiratory pressures 
also resulted in comparable levels for both groups (maximal 
sustainable ventilatory capacity/maximal inspiratory pressure: 
normal subjects 1.4 -C 0.3, heart failure group 1.1 t 0.8 
liters/kilopascal (kPa); maximal sustainable ventilatory capac- 
ity/maximal expiratory pressure: normal subjects 2.5 i 0.6, 
heart failure group 2.2 t- 1.3 litcl-s/kPa, both p > 0.3). 
Diminished static and dynamic cndurancc of the limb 
skeletal muscle may contribute to the exertional fatigue expe- 
rienced by patients with heart failure (8). Similarly dyspnea, a 
frequent limiting symptom in patients with heart failure, may 
also originate from abnormalities of muscle function (20-22). 
Previously, we have demonstrated accessory respiratory muscle 
deoxygenation during exercise in patients with heart failure 
(12). as well as marked increase in the work of the diaphragm 
as assessed by the tension-time index (13). In the present study, 
we used progressive isocapnic hyperpnea to investigate 
whether the endurance of the respiratory muscles is reduced in 
these patients. We also investigated the relation of respiratory 
muscle endurance to perceived dyspnea and peak exercise 
ventilation. 
To our knowit-dgc, respiratory muscle endurance has not 
kjeen previously measured in patients with heart failure. Re- 
duced maximal voluntary ventilation has been previously rc- 
ported (23). That finding would imply a similar reduction in 
maximal sustainable ventllatoly capacity, as maximal suslain- 
able ventilatory capacity usually corresponds to -40% to 60% 
of maximal voluntary ventilation. Indeed, our findings suggest 
diminished endurance of the respiratory muscles as assessed by 
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measurement of maximal sustainable ventilatory capacity. A 
wide range of maximal sustainable ventilatory capacity was 
observed in our patients. Thisvariability was not clearly related 
to functional class or exercise capacity and whether it results 
from a heterogeneity of intrinsic skeletal muscle dysfunction 
present in patients with heart failure is uncertain. In prior 
studies (l-4,7) in which the metabolic responses of skeletal 
muscle to exercise were analyzed, a similar heterogeneity of 
responses was &served. Alternatively, the variability in both 
the normal subjects and patients with heart failure may be 
related to differences in body size and conditioning status. 
Diminished respiratory muscle endurance was observed in 
our patients with heart failure despite the relatively preserved 
maximal strength of the inspiratoty and cxpiratory muscles. 
These tindings are similar to those of Minotti et al. (g), who 
observed diminished endurance but not strength of the limb 
skeletal musculature in such patients. We observed a wide 
variation in mcasurcment of maximal sustainable ventilatory 
capacity both in our patients with heart failure and in our 
normal subjects. This variation is probably related to the wide 
range of differences in body habitus and conditioning in the 
two groups. 
A potential mechanism for the decreased respiratory mus- 
cle endurance in patients with heart failure includes poor 
motivation, because maximal sustainable ventilatory capacity is 
a subjective test. However, attainment of similar Borg scale 
recordings at maximal sustainable ventilatory capacity in both 
groups suggests that this is not the differentiating factor. An 
abnormality of neuromuscular junction transmission may also 
lead to diminished respiratory muscle endurance. However, 
previous studies (8,13) in the limb skeletal muscle using tetanic 
nerve stimulation and in the respiratory muscles using trans- 
cutaneous phrenic nerve stimulation have not demonstrated 
any abnormalities in neuromuscular transmission in thcsc 
patients. 
Maintenance of end-tidal COz and arterial oxygenation at 
baseline levels makes chemoreceptor activation by increases in 
partial prcssun: of CO1 or decreases in partial pressure of 
oxygen an unlikely mechanism for the decreased endurance. 
Our study did not control for other potential factors, such as 
potassium, hydrogen ions or catecholamines, that can also 
stimulate chemoreceptors. 
NO significant deoxygenation of the scrratus anterior mus- 
cle, that is, accessory respiratory muscle, occurred during 
measurement of maximal sustainable ventilatory capacity. Our 
selection of the scrratus anterior muscle for near-infrared 
monitoring was mandated by technical restraints. Monitoring 
of the diaphragm or smaller accessory muscles was not possi- 
bl~. Evaluation of serratus anterior muscle oxygenation may be 
USefUl, as fatigue of the diaphragm and accessory respiratory 
mu&s occurs simultaneously during incremental resistive 
breathing (24). In patients with chronic asthma, an increased 
inspir’atory activity of the serratus anterior muscle during both 
quiet and forced breathing has been observed in electromyo- 
grams (2% If the serratus anterior muscle is representative of 
inspiratory muscles, then lack of significant deoxygenation 
during measurement of maximal sustainable ventilatory capac- 
ity suggests that the diminished endurance is independent of 
reduced muscle oxygenation and, therefore, muscle hypoper- 
fusion. However, skeletal muscle fatigue can still occur inde- 
pendent of muscle deoxygenation. 
The most likely mechanism for the decreased maximal 
sustainable ventilatory capacity is intrinsic skeletal muscle 
changes or airflow obstruction, or both. Previous studies (1-7) 
using phosphorus-31 magnetic resonance spectroscopy in pa- 
tients with heart failure have demonstrated metabolic abnor- 
malities in limb skeletal muscle characterized by decreased 
oxidative capacity and carrier shift to glycolytic metabolism. 
Histochemical skeletal ab~o~~~lities and generalized muscle 
atrophy have also been described in these patients. Recently, 
histologic abnormalities in the diaphragn~ of patients under- 
going heart transplantation have also been described (26). 
Malnutrition and chronic obstructive lung disease have been 
shown to affect diaphragmatic weight and histochemical vari- 
ables (27,28). Thus, intrinsic respiratory muscle changes may 
occur and contribute to the observed decreased respiratory 
muscle endurance. 
Airflow obstruction may also contribute to the decreased 
respiratory muscle endurance. Maximal sustainable ventilatory 
capacity was strongly correlated with the derived FEV, and 
with maximal voluntary ventilation. The duty cycle (i.e., the 
time in inspiration divided by the time per breath) 
increase with progressive isocapnic hyperpnea in patients with 
heart failure in contrast to the observed increase in the normal 
volunteers. This finding is analogous to obsetvations in pa- 
tients with chronic obstructive pulmonary disease (19). More- 
over, peak inspiratory and expiratory flow rates were also 
reduced in patients with heart faiiure. As all our subjects had 
normal pulmonary function test results, bronchial edema 
rather than significant airway obstructive disease is the prob- 
able cause of this reduction in our patients. abanes et al. (29) 
previously described bronchial hyperresponsiveness in patients 
with severely impaired left ventricular function after inhalation 
of the cholinergic agonist methacholine. Inhalation of the 
vasoconstrictive alpha-adrenergic agonist methoxamine pre- 
vented the methacholine-induced bronchial obstruction, sug- 
gesting that bronchial edema was a partial cause of the 
bronchial hyperreactivity. 
Although maximal sustainable ventilatoty capacity was re- 
duced in our patients with heart failure, we emphasize that the 
work performed by these patients may be similar to that of the 
normal subjects. External work performed by both groups is 
identical, although internal work is different. Increased work of 
breathing in patients with heart failure may be the mechanism 
producing the apparent diminished endurance. The prior right 
heart catherizations indicate that these patients had elevated 
pulmonary pressures, which will contribute to airflow obstruc- 
tion as well as to increased work of breathing. Unfortunately, 
the work of breathing was not measured inour study. Most 
probably, a combination of both increased work of breathing 
and decreased ndurance l ads to the reduction i  maximal 
sustainable ventilatory capacity. 
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No signi~cant accessory respi- 
trated during pro- 
subjects or patients 
with heart faihtre. In contrast, in QUF prior studies (la), 
uscle deo~geuat~~u was o 
exen-cise in patients with heart 
inute ~~e~tilat~ou is 
ventilatory capacity, it
is unhkecely due to differences in the activation of this muscle. 
These findings imply that adequate muscle perfusio 
with isolated respiratory uscle work, whereas during maximal 
bicycle exercise, blood is shunted from the respiratory 
f working skeletal muscle, that is, 
capacity and peak exercise ventilation were sig 
in patients with hoart failure than in normal subj 
these values were similar within each group. 
studies have examined peak exercise ventilation and maximal 
voluntary ventilation measured over a 15-s time interval. We 
know of no prior studies that have examined the correlation 
between maximal sustainable veut~lato~ capacity and peak 
exercise ventilation. The correlation observed between these 
two variables does not mean that the peak ventilation achieved 
during exercise is the maximum that could be achieved. It
suggests hat a test of respiratory muscle ndurance can predict 
peak exercise ventilation. This finding does not necessarily 
coutradict the prevailing notion that exercise in normal sub- 
jects and patients with heart failure is limited by cardiovascular 
status. However, in patients with heart failure, respiratory 
muscle weakness coupled with an increased mechanical work 
of breathing may set an upper limit on ventilatory capacity. 
Moreover, this finding does raise the possibility that specific 
respiratory muscle endurance training may improve maximal 
sustainable ventilatory capacity and exercise performance in 
both normal subjects and patients with heart failure. Leith and 
Bradley (30) demonstrated improved exercise performance in
normal subjects who underwent selective respiratory muscle 
training. Further studies are needed to investigate the effect on 
exercise performance of unloading the respiratory system. 
The correlation between maximal sustainable ventilatory 
capacity and peak exercise ventilation suggests that central 
control or pulmonary stretch mechanisms become inhibitory at 
a certain level of muscle activation or lung volume and that the 
mechanisms limiting peak minute ventilation and maximal 
sustainable ventilatory capacity are similar. The ventilatory 
muscles are innervated by a variety of sensory receptors, 
including muscle spindles, that monitor changes in muscle 
length and position sense. Changes in active muscle force 
stimulate t ndon organs, which exert an inhibitory influence on 
the medullary ventilatory activity. Lung mechanoreceptors also 
play a critical role in the feedback control of breathing. 
Afferents from the airways and the lung parenchyma by way of 
the vagus nerve provide information about lung expansion to 
the brain stem. Stimulation of these receptors could result in 
respiratory ~nb~b~tiou, That the tidal volumes at mammal 
susta~uab~e ventilatory capacity in both normal subjects and 
patients with heart failure only tended to increase over rest 
vheS suggests hat Jung volume is not the predominant signal. 
dings are complemzitary to those of Cabanes et aJ. 
demonstrated significant improvement in submaxi- 
mal and maximal exercise performance after inhafation of 
methoxamine in patients with heart failure who were limited by 
dyspnea. Both studies suggest a pulmonary contribution to 
peak exercise performance that has previously been unrecog- 
nized. 
Maximal sustainable ventilator-y capacity was significantly 
correlated to peak oxygen consumption for the whole group. 
owever, no significant correlations were observed for the 
i~~dividua~ groups, suggesting that the statistical significance is 
artifactual. Alternatively, the correlation between maximal 
sustainable v ntilatory capacity and peak oxygen consumption 
may reflect better muscle endurance and thus a subject’s 
capacity to do more work. 
uring maximal treadmill exercise and during the dctermi- 
nation of maximal sustainable ventilatory capacity, patients 
with beart failure and normal subjects achieved the same level 
of perceived yspnea. This o servation suggests hat a central 
mechanism originating from respiratory muscle activation 
helps to signal the level of perceived yspnea s well as the 
termination of exercise. The cur;elation observed between 
perceived yspnea t submaximal exercise and maximal sus- 
tainable venti;atory capacity also suggests an association be- 
tween these rwo variables. These resuhs are concordant wit? 
our prior study (13) in which variables of respiratory muscle 
function, such as strength, work and oxygenation, correlated 
with perceived yspnea. 
At maximal sustainable ventilatory capacity and with max- 
imal exercise, patients with heart failure may be close to levels 
of respiratory muscle fatigue. In a recent study by Johnson et 
al. (-i2), diaphragmatic fatigue was demonstrated by super- 
maximal bilateral transcutaneous phrenic nerve stimulation i  
healthy oung adults after endurance xercise to exhaustion. 
§tudy limitations. The protocol used to measure maximal 
sustainable ventilatory capacity varied from the traditional 
method used in published pulmonary studies. Classically, 15 
min work loads are used, beginning at 70% of maximal 
voluntary ventilation (19,33,34). We formulated our present 
protocol in light of concerns that the standard method would 
be too difficult for patients with heart failure. In the six normal 
subjects who underwent testing with both protocols, results for 
maximal sustainable v ntilator-y capacity were similar with the 
two methods. In patients with heart failure, maximal sustain- 
able ventilatory capacity corresponded to 65% of maximal 
voluntary ventilation, which is in the expected range. Thus, we 
believe that the approach we used was adequate. Moreover, 
with this protocol, we could complete measurements in a single 
day, whereas in previous protocols erial measurements have 
been performed on separate days. 
Another potential criticism is that the determination of 
maximal sustainable ventilatory capacity is based on subject 
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motivation. Because the end point is subjective, this measure- 
ment may bi: based on submaximal rather than maximal 
capacity. Nevertheless, because both groups achieved similar 
levels of perceived work as quantified by the Borg scale, this 
facior should not affect the observed results. A major limita- 
tion of our study is that the work of breathing was not 
measured. An increased work of breathing is the most likely 
mechanism for the observed reduction in maximal sustainable 
ventilatory capacity. 
Pqyessivc isocapnic hyperpnea h s been used as a stimu- 
lus ta provoke bronchoconstriction. The dead space mixing 
chamber incorporated into our apparatus should humidify the 
inspired air, None of our patients stopped isolated respiratory 
work bccause of mouth dryness. ft is unlikely that the reduced 
respiratary muscle endurance resulted from this mechanism. 
We did not measure FEV, dircctiy, but based it on dupli. 
cate maximal voluntary ventilation measurements. If FEVl 
had been directly measured, differences in lung restriction 
might have yielded slightly different results and the correlation 
observed between FEV, and maximal sustainable ventilatory 
capacity might have been weakened. 
The work and pressures of hypcrpnea at rest and during 
exercise are different, as demonstrated by pressure and flow 
volume loops. Therefore, comparison and correlation of max- 
imal sustainable ventilatory capacity with peak exercise minute 
ventilation must be viewed with caution (32). 
Summary and clinical implications. This study demon- 
strates greatly reduced respiratory muscle endurance in pa- 
tients with heart failure, This finding is important in that a 
generalized defect of skeletal muscle function is ested. 
Indeed, we (7) have previously demonstrated g alized 
skeletal muscle atrophy determined by anthropomorphic mea- 
surements in patients with heart failure in all functional 
ClasSeS. 
sts that respiratory muscle activatian 
may be one of the afferent signals leading to the termination of 
e~r&e. A correlation between respiratory muscle endurance 
and the perception of dyspnea is also suggested. Therefore, 
therapeutic interventions targeted to improve the function of 
the respiratory muscles may be effective in both improving 
maximal exercise performance and alleviating dyspnea. Nutri- 
tional supplementation, isolated respiratory muscle training or 
aerobic training, alone or in combination, may be beneficial in 
treating heart failure (35-37). Airflow obstruction also may be 
a possible mechanism for the reduced endurance. Agents that 
reduce bronchial edema such as diuretic drugs and aerosolized 
methoxamine (31) may also improve exercise performance and 
diminish dyspnea. Further studies are needed to investigate the 
effect of modifj’ing respiratory muscle function on both the 
iwrqtion of dyspnea and exercise performance. 
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